Navigation Links
World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc.
Date:11/4/2008

Gene therapy promises to be one of the most important frontiers in medicine. Although no significant achievements for curing disease have been achieved, the future seems to hold significant potential in terms of developing such approaches. By the year 2015, global market for gene therapy is projected to reach $484 million.

San Jose, CA (PRWEB) November 4, 2008 -- Advancements in gene therapy have provided useful data, which has helped in understanding the pathogenesis of diseases. The discipline heralds a significant potential for the biotechnology industry over the next 20 years, as the approach moves from research labs to clinical trials. Proteins and monoclonal antibodies have revolutionized the treatment of a wide variety of diseases, and gene-based therapies that deliver the DNA sequences encoding proteins and antibodies signify the next big step in the evolution of biopharmaceuticals.

Gene therapy market is still in the experimental stages with success yet to be achieved in developing completely curative therapeutic drugs, as stated in a recent report published by Global Industry Analysts, Inc. Till date, only one gene therapy drug Gendicine, developed by Shenzhen SiBiono Gene Technologies Co., has been approved, which is marketed in China. Market predictions for gene therapy highly depend on the regulatory approval of products currently in clinical trials. Most gene therapy products for cancer and cardiovascular diseases are in Phase III/ Phase II of clinical trials. Cost of the treatment and disease population are the other factors that affect the gene therapy market. Funding and research developments and acceptance of gene therapy products to use in medicine are also expected to impact the market in the near future.

Gene therapy industry comprises of biotech, pharmaceutical companies, research, and academic institutions. Leading biotech companies operating in gene therapy marketplace include AnGes MG Inc, Cell Genesys, GenVec, Genzyme Corporation, Introgen Therapeutics Inc, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd, Targeted Genetics Corp, Transgene, Urigen Pharmaceuticals Inc., and Vical.

The report, titled "Gene Therapy: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides comprehensive insight into the industry dynamics, and highlights noteworthy market drivers, challenges, and trends shaping the market. The report also enumerates recent industry developments, and outlines the gene therapy products under development. Analysis is provided for the period 2007-2015.

For more details about this research report, please visit http://www.strategyr.com/Gene_Therapy_Market_Report.asp.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @ StrategyR.com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/gene_therapy/biotechnology/prweb1563264.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Complete Genomics Chooses Isilon IQ to Power Worlds First Complete Human Genome Sequencing Service
2. From Race Cars and Google Doodles to Day Spas and Night Lights: Groups Across the U.S. Prepare to Join World Diabetes Day Celebrations on November 14
3. Orange and Medic4all Launched the Worlds First Cellular Tele-Health Service
4. TechConnect World 2009 Matches Tomorrows Technology Solutions with Todays Business Needs for Clean-Technology, Biotechnology and Nanotechnology
5. Can Algae Biofuels Satisfy the World's Growing Biofuel Needs? Upcoming Webinar Shares the Latest Commercialization Strategies and Challenges
6. McMaster University unveils worlds most advanced microscope
7. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
8. Lilly Recognized as One of the Worlds Top Biopharmaceutical Employers
9. Millennium Ranks in the Top 10 Best Biopharma Employers in the World by Science Magazine
10. World Sight Day - Britons at Risk of Losing Their Sight by Not Having Regular Eye Tests
11. [video] Dr. Tony Milici, Chairman and CEO of GeneThera, Inc., Discusses Worldwide Rights to E.Coli Vaccine on WallSt.nets 3-Minute Press Show
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc.
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... Calif. , June 23, 2016  Blueprint Bio, ... biological discoveries to the medical community, has closed its ... Matthew Nunez . "We have received ... with the capital we need to meet our current ... essentially provide us the runway to complete validation on ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology:
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):